Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02723955
Title Dose Escalation and Expansion Study of GSK3359609 in Subjects With Selected Advanced Solid Tumors (INDUCE-1)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: child
Covered Countries USA | NLD | ITA | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
GSK Investigational Site Duarte California 91010 United States Details
GSK Investigational Site Los Angeles California 90025 United States Details
GSK Investigational Site Sarasota Florida 34232 United States Details
GSK Investigational Site New York New York 10016 United States Details
GSK Investigational Site New York New York 10032 United States Details
GSK Investigational Site Oklahoma City Oklahoma 73104 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19111 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Nashville Tennessee 37232-6307 United States Details
GSK Investigational Site Heidelberg Victoria 3084 Australia Details
GSK Investigational Site Melbourne Victoria 3000 Australia Details
GSK Investigational Site Nedlands Western Australia 6009 Australia Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Shnghai 200126 China Details
GSK Investigational Site Bordeaux Cedex 33076 France Details
GSK Investigational Site Lyon cedex 08 69373 France Details
GSK Investigational Site Paris 75005 France Details
GSK Investigational Site Villejuif cedex 94805 France Details
GSK Investigational Site Siena Toscana 53100 Italy Details
GSK Investigational Site Chiba 277-8577 Japan Details
GSK Investigational Site Osaka 589-8511 Japan Details
GSK Investigational Site Tokyo 104-0045 Japan Details
GSK Investigational Site Amsterdam 1066 CX Netherlands Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Barcelona 08036 Spain Details
GSK Investigational Site Madrid 28040 Spain Details
GSK Investigational Site Málaga 29010 Spain Details
GSK Investigational Site Sevilla 41009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field